miR-652 protects rats from cerebral ischemia/reperfusion oxidative stress injury by directly targeting NOX2

Mei-Ling Zuo1, Ai-Ping Wang2, Gui-Lin Song3

  • 1Office of Good Clinical Practice, The Affiliated Changsha Hospital of Hunan Normal University, Changsha, 410006, Hunan, China.

Insights

MicroRNA-652 (miR-652) protects against ischemic stroke by targeting NOX2, reducing oxidative stress and brain tissue damage. This finding offers a new therapeutic target for stroke treatment.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Ischemic stroke is a major cause of central nervous system damage, linked to oxidative stress.
  • NADPH oxidase 2 (NOX2) is a primary source of reactive oxygen species (ROS) implicated in brain injury.
  • MicroRNAs (miRNAs) regulate gene expression and play a role in ischemic stroke pathogenesis.

Purpose of the Study:

  • To investigate the role of microRNA-652 (miR-652), a potential target of NOX2, in ischemic stroke.
  • To elucidate the therapeutic potential of targeting miR-652 in cerebral ischemia-reperfusion injury.

Main Methods:

  • Established rat cerebral ischemia/reperfusion (CI/R) and SH-SY5Y cell hypoxia/reoxygenation (H/R) models.
  • Measured gene expression, biochemical, and pathophysiological indicators.
  • Utilized miR-652 overexpression and agomir treatments in cellular and animal models.

Main Results:

  • NOX2 expression increased, while miR-652 levels decreased in both CI/R and H/R models.
  • miR-652 overexpression suppressed NOX2, reduced ROS generation, and mitigated cell damage.
  • miR-652 agomir treatment decreased NOX2, ROS, and brain tissue injury in CI/R rats.

Conclusions:

  • miR-652 directly targets NOX2, offering protection against cerebral ischemia-reperfusion injury.
  • miR-652 represents a novel therapeutic target for treating ischemic stroke.

Related Concept Videos